• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Bayer Aktienges ADR (OP: BAYRY )

    6.770 -0.040 (-0.59%)
    Streaming Delayed Price Updated: 3:59 PM EDT, Oct 31, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 1,365,996
    Open 6.830
    Bid (Size) N/A (0)
    Ask (Size) N/A (0)
    Prev. Close 6.810
    Today's Range 6.740 - 6.840
    52wk Range 6.740 - 11.34
    Shares Outstanding N/A
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Bayer Seeks European Approval For Its Menopause Drug
    Bayer has submitted an MAA to the EMA for elinzanetant, targeting moderate to severe vasomotor symptoms linked to menopause. Phase 3 trials showed significant reductions in VMS and improved quality of... 
    Via Benzinga
    Bayer Seeks European Approval For Third Indication For Cancer Drug Darolutamide
    Bayer is seeking EMA approval for darolutamide in metastatic hormone-sensitive prostate cancer, building on promising Phase III ARANOTE trial results. The treatment significantly lowers progression... 
    Via Benzinga

    Performance

    YTD
    -27.83%
    -27.83%
    1 Month
    -19.50%
    -19.50%
    3 Month
    -8.88%
    -8.88%
    6 Month
    -10.92%
    -10.92%
    1 Year
    -36.33%
    -36.33%

    More News

    Read More
    Week In Review: Zenas Raises $259 Million In IPO
    Via Talk Markets
    Topics Initial Public Offering
    Exposures Securities Market
    Regeneron Dives As Amgen Tees Up Its Rival To Moneymaking Machine Eylea
    Via Investor's Business Daily
    “Signing Day Sports, Inc. (NYSE American: SGN) Soars in Pre-Market on Acquisition News – see more penny stocks inside….”
    Via AB Newswire
    Bayer Targets Expanded Use Approval For Prostate Cancer Drug, Reveals Encouraging Data From Pivotal Study
    Via Benzinga
    Roivant Sciences Unveils New 'Vant' Subsidiary For In-Licensed Pulmonary Hypertension Drug From Bayer
    Via Benzinga
    Why Is BridgeBio Pharma Stock Trading Higher On Friday?
    Via Benzinga
    BAYRY Stock Earnings: Bayer Meets EPS, Beats Revenue for Q2 2024
    Via InvestorPlace
    Bayer Weedkiller Lawsuit Dismissed By Australian Judge: Insufficient Evidence Linking Roundup To Blood Cancer
    Via Benzinga
    Topics Lawsuit
    Exposures Financial Glyphosate Legal
    ScottsMiracle-Gro Stock Blooms After Investor Day Optimism
    Via MarketBeat
    Topics Cannabis
    Exposures Cannabis
    3 Longevity Stocks to Buy for Anti-Aging Breakthroughs
    Via InvestorPlace
    3 Small-Cap Stocks With Explosive 2X Growth Potential
    Via InvestorPlace
    Judge Slashes Bayer's Massive $2B Roundup Verdict To $400M
    Via Benzinga
    Exposures Glyphosate
    Week In Review: MediLink And BioNTech Form $1.8 Billion ADC Partnership
    Via Talk Markets
    European Equities Close Higher As Traders Bank On Imminent ECB Rate Cut: What's Driving Markets Monday?
    Via Benzinga
    After UnitedHealth Cyberattack, Drug Distributor Cencora Notifies Americans' Health Information Stolen In Data Breach In February
    Via Benzinga
    Topics Data Breach
    Exposures Information Security
    Bayer Highlights Detailed Data From Twin Late-Stage Trials On Experimental Menopause Candidate, Seeks Regulatory Approval
    Via Benzinga
    Pfizer, AstraZeneca, Sanofi And Mainz Biomed To Uplevel Europe's Pharma Game
    Via Benzinga
    BAYRY Stock Earnings: Bayer Beats EPS, Misses Revenue for Q1 2024
    Via InvestorPlace
    From Hype To Reality, AI Reshapes Pharmaceutical Industry Across Drug Discovery To Marketing - Stocks To Watch
    Via Benzinga
    Topics Artificial Intelligence
    Exposures Artificial Intelligence
    Bayer's Monsanto Scores Legal Victory as $185M Verdict Overturned
    Via Benzinga
    Exposures Glyphosate
    Alphabet, Nasdaq, Spotify, Teck Resources And A Major Financial Stock On CNBC's 'Final Trades'
    Via Benzinga
    Google Partners With European Conglomerate Bayer For New AI-Powered Solutions For Radiologists
    Via Benzinga
    Topics Artificial Intelligence
    Exposures Artificial Intelligence
    Wondering Where To Find An Over 7% Annual Return? Check Out These 10 Investment-Grade Corporate Bonds
    Via Benzinga
    Topics Bonds
    Exposures Debt Markets
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.